BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18324930)

  • 1. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene.
    Priore Oliva C; Carubbi F; Schaap FG; Bertolini S; Calandra S
    J Intern Med; 2008 Apr; 263(4):450-8. PubMed ID: 18324930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
    Calandra S; Priore Oliva C; Tarugi P; Bertolini S
    Curr Opin Lipidol; 2006 Apr; 17(2):122-7. PubMed ID: 16531747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia.
    Pisciotta L; Fresa R; Bellocchio A; Guido V; Priore Oliva C; Calandra S; Bertolini S
    Clin Chim Acta; 2011 Nov; 412(23-24):2194-8. PubMed ID: 21846464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia.
    Priore Oliva C; Pisciotta L; Li Volti G; Sambataro MP; Cantafora A; Bellocchio A; Catapano A; Tarugi P; Bertolini S; Calandra S
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):411-7. PubMed ID: 15591215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
    Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
    J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
    Charrière S; Cugnet C; Guitard M; Bernard S; Groisne L; Charcosset M; Pruneta-Deloche V; Merlin M; Billon S; Delay M; Sassolas A; Moulin P; Marçais C
    Atherosclerosis; 2009 Nov; 207(1):150-6. PubMed ID: 19447388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
    Marçais C; Verges B; Charrière S; Pruneta V; Merlin M; Billon S; Perrot L; Drai J; Sassolas A; Pennacchio LA; Fruchart-Najib J; Fruchart JC; Durlach V; Moulin P
    J Clin Invest; 2005 Oct; 115(10):2862-9. PubMed ID: 16200213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.
    Dussaillant C; Serrano V; Maiz A; Eyheramendy S; Cataldo LR; Chavez M; Smalley SV; Fuentes M; Rigotti A; Rubio L; Lagos CF; Martinez JA; Santos JL
    BMC Med Genet; 2012 Nov; 13():106. PubMed ID: 23151256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia.
    Hooper AJ; Kurtkoti J; Hamilton-Craig I; Burnett JR
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):485-9. PubMed ID: 24591733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.
    Hubacek JA; Wang WW; Skodová Z; Adámková V; Vráblík M; Horínek A; Stulc T; Ceska R; Talmud PJ
    Clin Chem Lab Med; 2008; 46(6):773-7. PubMed ID: 18601597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
    Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
    Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency.
    Okubo M; Toromanovic A; Ebara T; Murase T
    Clin Chim Acta; 2015 Jan; 438():148-53. PubMed ID: 25172036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
    Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
    Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
    Dorfmeister B; Zeng WW; Dichlberger A; Nilsson SK; Schaap FG; Hubacek JA; Merkel M; Cooper JA; Lookene A; Putt W; Whittall R; Lee PJ; Lins L; Delsaux N; Nierman M; Kuivenhoven JA; Kastelein JJ; Vrablik M; Olivecrona G; Schneider WJ; Heeren J; Humphries SE; Talmud PJ
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1866-71. PubMed ID: 18635818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Case of a Homozygous Deletion in the
    Vasiluev PA; Ivanova ON; Semenova NA; Strokova TV; Taran NN; Chubykina UV; Ezhov MV; Zakharova EY; Dadli EL; Kutsev SI
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
    Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.
    Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y
    Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.